Q3 EPS Forecast for Colgate-Palmolive Boosted by Analyst

Key Points

• Zacks Research raised Colgate-Palmolive’s Q3 2026 EPS forecast to $0.92 from $0.91, while projecting full-year 2026 EPS of $3.85 and 2027 EPS of $4.05.
• Analyst sentiment remains favorable, with 12 Buy ratings and seven Holds producing a consensus “Moderate Buy” rating and an average price target of $99.
• Colgate-Palmolive recently exceeded quarterly EPS expectations, reporting $0.99 versus the $0.95 consensus, while revenue rose 4.9% year over year to $5.36 billion; its quarterly dividend equates to a 2.3% yield.

Colgate-Palmolive Company (NYSE:CL - Free Report) - Equities researchers at Zacks Research increased their Q3 2026 earnings per share estimates for shares of Colgate-Palmolive in a report released on Friday, August 14th. Zacks Research analyst Team now expects that the company will earn $0.92 per share for the quarter, up from their previous forecast of $0.91. The consensus estimate for Colgate-Palmolive's current full-year earnings is $3.86 per share. Zacks Research also issued estimates for Colgate-Palmolive's Q4 2026 earnings at $0.97 EPS, FY2026 earnings at $3.85 EPS, Q1 2027 earnings at $1.00 EPS, Q2 2027 earnings at $1.03 EPS, FY2027 earnings at $4.05 EPS and FY2028 earnings at $4.36 EPS.

Several other equities research analysts have also commented on the company. Citigroup boosted their price objective on Colgate-Palmolive from $105.00 to $110.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Royal Bank Of Canada lifted their price target on Colgate-Palmolive from $102.00 to $104.00 and gave the stock an "outperform" rating in a research note on Monday, August 3rd. Sanford C. Bernstein reiterated a "market perform" rating on shares of Colgate-Palmolive in a research report on Thursday. Weiss Ratings reissued a "hold (c+)" rating on shares of Colgate-Palmolive in a research note on Friday, July 31st. Finally, Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $92.00 to $95.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 8th. Twelve research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $99.00.

Colgate-Palmolive Stock Down 0.1%

CL opened at $91.90 on Monday. The company has a market cap of $73.26 billion, a PE ratio of 36.47, a price-to-earnings-growth ratio of 4.48 and a beta of 0.33. Colgate-Palmolive has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a 50-day moving average price of $91.67 and a 200 day moving average price of $90.02. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion for the quarter, compared to analysts' expectations of $5.36 billion. During the same quarter last year, the company earned $0.92 EPS. The firm's revenue for the quarter was up 4.9% compared to the same quarter last year.

Institutional Trading of Colgate-Palmolive

Hedge funds and other institutional investors have recently made changes to their positions in the company. Kemnay Advisory Services Inc. acquired a new stake in Colgate-Palmolive during the fourth quarter worth $25,000. CBIZ Investment Advisory Services LLC grew its holdings in shares of Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company's stock worth $26,000 after purchasing an additional 150 shares during the period. TD Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 61.4% during the 4th quarter. TD Capital Management LLC now owns 326 shares of the company's stock worth $26,000 after purchasing an additional 124 shares during the period. Triumph Capital Management increased its position in shares of Colgate-Palmolive by 62.9% during the 4th quarter. Triumph Capital Management now owns 329 shares of the company's stock worth $26,000 after purchasing an additional 127 shares during the last quarter. Finally, Jessup Wealth Management Inc purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $26,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of the firm's stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total value of $14,801,050.32. Following the completion of the sale, the chief executive officer directly owned 362,231 shares of the company's stock, valued at $33,296,273.52. This trade represents a 30.77% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.43% of the stock is owned by corporate insiders.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, July 20th were paid a dividend of $0.53 per share. The ex-dividend date of this dividend was Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive's payout ratio is 84.13%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source